Normal adjacent-to-tumor (NAT) tissues, widely used as "normal" controls, are increasingly recognized as molecularly distinct from both tumor and healthy tissues, reflecting early carcinogenic alterations rather than a true normal state. Here, BRD2 is linked to neoplasm.